NOTA:FRA
Novartis AG
€126.00
arrow_upward
+0.80%(+1.00) 1D
Sep 29, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOTA...
Open
€126.00
High
€126.00
Low
€126.00
Mkt. cap
295.89B
Avg. vol.
27.00
Volume
0.00
52-wk high
€145.00
52-wk low
€102.50
No. of employees
75K
Open
€126.00
High
€126.00
Low
€126.00
Mkt. cap
295.89B
Avg. vol.
27.00
Volume
0.00
52-wk high
€145.00
52-wk low
€102.50
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Novartis stock after-hours at EUR 128.09: minus 0.88 percent versus prior close
AD HOC NEWS
·
10 hours ago
Novartis stock follows Goldman Sachs cut to CHF 110.00 target
BioSpace
·
17 hours ago
3 steps for taking on Novartis in radiopharma: Curium up first
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com